August 24, 2020
In re Vaxart, Inc. Securities Litigation
Case Number:
3:20-cv-05949
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Akin Gump
- Baker Botts
- Baker McKenzie
- Berman Tabacco
- Bleichmar Fonti
- Boies Schiller
- Conrad Metlitzky
- Goodwin Procter
- Hagens Berman
- Hanson Bridgett
- Paul Hastings
- Robbins LLP
- Scott&Scott
- Thompson Hine
- Umhofer Mitchell
- Williams & Connolly
- Willkie Farr
- Wilson Elser
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 14, 2026
Armistice Capital Used COVID To Juice Vaxart Stock, Jury Told
Hedge fund Armistice Capital and two of its executives exploited the COVID-19 pandemic to issue press releases that falsely inflated their controlling share in pharmaceutical company Vaxart, then dumped the shares for $250 million before the bottom fell out, investors told a California federal jury at the start of trial Tuesday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login